Results 11 to 20 of about 19,724 (181)
Hydroxychloroquine (HQ) and quinacrine are widely used antimalarials for systemic lupus erythematosus (SLE) and other autoimmune diseases. We report a case of antimalarial-induced hyperpigmentation in a 57-year old African-American woman. The patient had
Daniel Kwak, Pearl E. Grimes, MD
doaj +1 more source
Disease stability in segmental and non-segmental vitiligo
Introduction: Some therapeutic decisions in vitiligo depend on the likelihood of the disease remaining stable and inactive. Aim: To determine a period of disease stability in vitiligo following which reactivation was unlikely. Materials and Methods: This
Neha Taneja+4 more
doaj +1 more source
New oral and topical approaches for the treatment of melasma
Melasma is a common, therapeutically challenging, and universally relapsing disorder of hyperpigmentation that is most often observed in women and individuals with Fitzpatrick Skin Types III through VI. The pathogenesis of melasma is complex and protean.
P.E. Grimes, MD+3 more
doaj +1 more source
Background: Vitiligo is a common acquired hypopigmentation skin condition defined by an idiopathic, gradual, and restricted loss of melanin pigment from otherwise healthy-looking skin.
Fatmah Ahmed Keraryi+4 more
doaj +1 more source
Background: Many international studies have been conducted to assess the knowledge, attitudes and practices (KAP) of the public toward sun exposure and sun-protection measures.
Khalid M. AlGhamdi+2 more
doaj +1 more source
Background Vitiligo is the most common skin depigmentation disorder. Melatonin is a hormone that affects melanogenesis and pigmentation. The possible role of melatonin in the pathogenesis of vitiligo remains unclear.
Shereen Adel+3 more
doaj +1 more source
Background/aim: Although complementary and alternative medicine (CAM) use is highly prevalent, there is very limited information on dermatologists’ attitudes and knowledge about CAM.
Khalid M. AlGhamdi+2 more
doaj +1 more source
Background: Vitiligo is a common pigmentary skin disorder, affecting 0.5–1% of world population. It is one of the psychologically devastating skin disorders, which have different medical and surgical modalities of treatment.
Norah Alsubait+2 more
doaj +1 more source
MicroRNAs: Emerging players in the pathogenesis of vitiligo
Vitiligo is an autoimmune skin disease characterized by presence of pale patchy areas of depigmentation. MicroRNAs (miRNAs) are important regulators of gene expression and play significant roles in diverse biological and pathological processes ...
Xin Yu+5 more
doaj +1 more source
Clinical Features of Vitiligo and Social Impact on Quality of Life
Vitiligo is the most common cause of depigmentation and its estimated worldwide prevalence ranges from 0.5% to 2%. The disease is characterized by the development of white macules resulting from a loss of epidermal melanocytes.
Seneschal Julien
doaj +1 more source